The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.
Category: Health Industry
Texas Lawmakers Take Aim At Surprise Medical Bills
A bill with bipartisan, bicameral support is on the move in Texas. It would force hospitals and insurers to settle surprise bills — instead of relying on patients to start the mediation process. The KHN/NPR “Bill of the Month” series is a catalyst for the effort.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Look Up Your Hospital: Is It Being Penalized By Medicare?
Each year, Medicare punishes hospitals that have high rates of readmissions and high rates of infections and patient injuries. Check out which hospitals have been penalized.
Medicare Trims Payments To 800 Hospitals, Citing Patient Safety Incidents
The penalties are part of a program set up by the Affordable Care Act to prompt hospitals to pay more attention to safety issues that can lead to injuries, such as falls or hospital-acquired infections.
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.
Cancer’s Complications: Confusing Bills, Maddening Errors And Endless Phone Calls
Carol Marley has pancreatic cancer — and dealing with its financial toll has become her full-time job.
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
